{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:54:20Z","timestamp":1780577660421,"version":"3.54.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bpobgyn.2007.07.001","type":"journal-article","created":{"date-parts":[[2007,8,31]],"date-time":"2007-08-31T11:14:59Z","timestamp":1188558899000},"page":"251-260","source":"Crossref","is-referenced-by-count":20,"title":["Hormonal management of premenstrual syndrome"],"prefix":"10.1016","volume":"22","author":[{"given":"Sa'adatu Bose","family":"Usman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radha","family":"Indusekhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaughn","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2007.07.001_bib1","first-page":"50","article-title":"Premenstrual syndrome: making sense of the options","volume":"65","author":"Panay","year":"2005","journal-title":"Pulse"},{"issue":"Supplement 3","key":"10.1016\/j.bpobgyn.2007.07.001_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0306-4530(03)00098-2","article-title":"The prevalence, impairment, impact and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib3","first-page":"1743","article-title":"Premenstrual syndrome","volume":"67","author":"Dickerson","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00023210-200317050-00003","article-title":"The role of hormones and hormonal treatments in premenstrual syndrome","volume":"17","author":"Backstrom","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/09513599209081007","article-title":"Buserilin in premenstrual syndrome","volume":"6","author":"Hussain","year":"1992","journal-title":"J Gynaecol Endocrinol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3109\/00016348509155154","article-title":"Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen\u2013progestogen postmenopausal replacement treatment","volume":"64","author":"Hammarback","year":"1985","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0029-7844(97)00417-1","article-title":"Progesterone metabolite allopregnanolone in women with premenstrual syndrome","volume":"90","author":"Rapkin","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/sj.mp.4001362","article-title":"GABAergic dysfunction in mood disorders","volume":"8","author":"Brambilla","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1055\/s-2007-978871","article-title":"Allopregnanolone in women with premenstrual syndrome","volume":"30","author":"Bicikova","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib10","first-page":"23","article-title":"Neuroendocrine correlates of premenstrual syndrome","volume":"11","author":"Genazzani","year":"2006","journal-title":"Gynaecol Forum"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0091-3057(00)00299-9","article-title":"Neurosteroids and reward: allopregnanolone produces a conditioned place aversion in rats","volume":"67","author":"Beauchamp","year":"2000","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.yhbeh.2003.04.002","article-title":"Neurosteroids, GABA receptors, and escalated aggressive behaviour","volume":"44","author":"Miczek","year":"2003","journal-title":"Horm Behav"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.curobgyn.2004.09.003","article-title":"Premenstrual syndrome","volume":"15","author":"Ismail","year":"2005","journal-title":"Curr Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib14","first-page":"20","article-title":"Hormones and premenstrual syndrome","volume":"11","author":"Backstrom","year":"2006","journal-title":"Gynaecol Forum"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib15","first-page":"5","article-title":"Diagnosis of premenstrual syndrome","volume":"11","author":"Halbreich","year":"2006","journal-title":"Gynaecol Forum"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib16","first-page":"68","article-title":"Effects of the menstrual cycle on medical disorders","volume":"33","author":"Magos","year":"1985","journal-title":"Br J Hosp Med"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib17","series-title":"Psychological Disorders in Obstetrics and Gynaecology for the MRCOG and Beyond","author":"Ismail","year":"2006"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003415.pub2","article-title":"Progesterone for premenstrual syndrome","volume":"4","author":"Ford","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib19","first-page":"589","article-title":"Investigations of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome","volume":"45","author":"Magill","year":"1995","journal-title":"Br J Gen Pract"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01674829609025661","article-title":"Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration","volume":"17","author":"Veneslow","year":"1996","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib21","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.323.7316.776","article-title":"Efficacy of progesterone and progestogens in the management of premenstrual syndrome: systematic review","volume":"323","author":"Wyatt","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib22","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0140-6736(89)90784-8","article-title":"Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone","volume":"2","author":"Watson","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib23","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1136\/bmj.293.6561.1540","article-title":"Prevention of premenstrual migraine by percutaneous oestradiol","volume":"293","author":"De Ligieres","year":"1986","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib24","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/bmj.292.6536.1629","article-title":"Treatment of premenstrual syndrome by subcutaneous oestradiol implants and cyclical oral norethisterone: placebo controlled study","volume":"292","author":"Magos","year":"1986","journal-title":"BMJ"},{"issue":"Supplement 3","key":"10.1016\/j.bpobgyn.2007.07.001_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0306-4530(03)00096-9","article-title":"A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder","volume":"28","author":"Rapkin","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1089\/15246090152543148","article-title":"Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder","volume":"10","author":"Freeman","year":"2001","journal-title":"J Womens Health Gend Based Med"},{"issue":"Supplement 11","key":"10.1016\/j.bpobgyn.2007.07.001_bib27","first-page":"985","article-title":"Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drosperinone","volume":"47","author":"Dickerson","year":"2002","journal-title":"J Reprod Med"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3999(92)90090-O","article-title":"A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive","volume":"36","author":"Graham","year":"1992","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with or without \u2018addback\u2019 therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0306-4530(94)00053-D","article-title":"A randomised, placebo-controlled crossover trail of danazol for the treatment of premenstrual syndrome","volume":"20","author":"Hahn","year":"1995","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib31","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0015-0282(16)54718-9","article-title":"Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndrome","volume":"56","author":"Halbriech","year":"1991","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1445-2197.1994.tb02221.x","article-title":"Mastalgia: a 3-year Australian study","volume":"64","author":"Wetzig","year":"1994","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib33","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9378(99)70142-0","article-title":"Randomised controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol","volume":"180","author":"O'Brien","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib34","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0015-0282(01)01668-5","article-title":"Symptomatic treatment of premenstrual mastalgia in premenstrual women with lisuride maleate: a double-blind placebo-controlled randomised study","volume":"75","author":"Kaleli","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib35","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0140-6736(76)90062-3","article-title":"Premenstrual tension and functional infertility: aetiology and treatment","volume":"1","author":"Benedek-Jaszmann","year":"1976","journal-title":"Lancet"},{"issue":"Supplement","key":"10.1016\/j.bpobgyn.2007.07.001_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5694\/j.1326-5377.1978.tb77381.x","article-title":"Prolactin suppression in the treatment of premenstrual tension syndrome","volume":"2","author":"Graham","year":"1978","journal-title":"Med J Aust"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib37","first-page":"723","article-title":"Bromocriptine in the treatment of premenstrual tension syndrome","volume":"56","author":"Elsner","year":"1980","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib38","first-page":"292","article-title":"Bromocriptine and norethisterone in the treatment of premenstrual syndrome","volume":"58","author":"Ylostalo","year":"1981","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib39","first-page":"242","article-title":"Bromocriptine (Bromergon, Lek) in the management of premenstrual syndrome","volume":"19","author":"Meden-Vrtovec","year":"1992","journal-title":"Clin Exp Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib40","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-0528.1979.tb10582.x","article-title":"Treatment of premenstrual syndrome by spironolactone","volume":"86","author":"O'Brien","year":"1979","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib41","first-page":"120","article-title":"Spironolactone in the treatment of premenstrual tension: a double-blind study of spironolactone versus bendroflumethiaxide and placebo","volume":"49","author":"Aslaksen","year":"1991","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib42","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1185\/03007998709112403","article-title":"A double-blind, placebo-controlled evaluation of spironolactone in the premenstrual syndrome","volume":"10","author":"Vellacott","year":"1987","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0020-7292(91)90357-B","article-title":"Premenstrual tension: a placebo-controlled efficacy study with spironolactone and medroxyprogesterone acetate","volume":"34","author":"Hellberg","year":"1991","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3109\/00016349509021201","article-title":"Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study","volume":"74","author":"Wang","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib45","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1479-828X.1991.tb02824.x","article-title":"Premenstrual syndrome and spironolactone","volume":"31","author":"Burnet","year":"1991","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib46","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0140-6736(00)02754-9","article-title":"Efficacy of selective serotonin re-uptake inhibitors in premenstrual syndrome: a systematic review","volume":"356","author":"Dimmock","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0029-7844(02)02166-X","article-title":"Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo- controlled, clinical trial using computerized diaries","volume":"100","author":"Cohen","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib48","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0306-5456(00)00120-0","article-title":"The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder","volume":"108","author":"Steiner","year":"2001","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib49","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0029-7844(02)02326-8","article-title":"Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder","volume":"100","author":"Halbreich","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib50","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00004714-199810000-00007","article-title":"Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phase more effective than continuous medication throughout the menstrual cycle?","volume":"18","author":"Wikander","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib51","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ajog.2005.01.021","article-title":"Luteal phase dosing with paroxetine controlled release in the treatment of premenstrual dysphoric disorder","volume":"193","author":"Steiner","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib52","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00004714-199708000-00004","article-title":"Comparison of fluoxetine, bupropion and placebo in the treatment of premenstrual dysphoric disorder","volume":"17","author":"Pearlstein","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib53","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1001\/archpsyc.56.10.932","article-title":"Differential response to antidepressants in women with premenstrual syndrome\/premenstrual dysphoric disorder: a randomised controlled trial","volume":"56","author":"Freeman","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib54","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/152460900318623","article-title":"A synergistic effect of a daily supplement for one month of 200 mg magnesium plus 50 mg Vit B6 for the relief of anxiety related premenstrual symptoms: a randomised, double blind, crossover study","volume":"9","author":"De Souza","year":"2000","journal-title":"J Women's Health Gend Based Med"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib55","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0022-3999(98)00042-7","article-title":"Cognitive therapy for premenstrual syndrome","volume":"45","author":"Blake","year":"1998","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib57","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.322.7279.134","article-title":"Treatment for the premenstrual syndrome with Agnus castus fruit extract: prospective randomised placebo controlled study","volume":"322","author":"Schellenberg","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib58","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0197-2456(95)00082-8","article-title":"Is evening primrose oil of value in the treatment of premenstrual syndrome?","volume":"17","author":"Budeiri","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib59","first-page":"6678","article-title":"The effects of aerobic exercise on premenstrual syndrome symptoms","volume":"56","author":"Bibi","year":"1995","journal-title":"Dissert Abst Int"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib60","first-page":"649","article-title":"Alleviation of premenstrual syndrome symptoms with the relaxation response","volume":"75","author":"Goodale","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.bpobgyn.2007.07.001_bib61","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1093\/humrep\/deh354","article-title":"Hysterectomy and bilateral oophorectomy for severe premenstrual syndrome","volume":"19","author":"Cronje","year":"2004","journal-title":"Hum Reprod"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693407001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693407001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T23:47:29Z","timestamp":1684021649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693407001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":61,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S1521693407001253"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2007.07.001","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}